Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Incubated by ARCH Venture Partners and backed by leading healthcare and life sciences investors, Paradigm Health aims to break down barriers across the trial ecosystem through one seamless infrastructure implemented at healthcare provider organizations, bringing potentially life-saving therapies to patients faster.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/04/25 | $78,000,000 | Series B |
ARCH Venture Partners DFJ Growth F-Prime Capital Partners General Catalyst GV Lux Capital Mubadala Capital The American Cancer Society Bright Edge | undisclosed |
